Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital)(Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital))

概要

基本信息

药物类型

生长因子

别名

MPC-NGF(Beijing Tiantan Hospital)

靶点-

作用方式-

作用机制-

治疗领域

神经系统疾病内分泌与代谢疾病其他疾病

在研适应症

肌萎缩侧索硬化

非在研适应症-

原研机构

北京天坛医院

在研机构

北京天坛医院

非在研机构-

最高研发阶段临床2/3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital) 相关的临床试验

NCT06391645

/ Not yet recruiting临床2/3期IIT

Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is one of the most lethal neurodegenerative diseases, with most patients dying from respiratory failure 3-5 years after the onset. The purpose of this study is to explore the efficacy and safety of nerve growth factor (NGF) encapsulated with 2-methacryloyloxyethyl phosphorylcholine (MPC) nanocapsules in the treatment of ALS patients.

开始日期2024-05-01

申办/合作机构

北京天坛医院

[+1]

100 项与 Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital) 相关的临床结果

登录后查看更多信息

100 项与 Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital) 相关的转化医学

登录后查看更多信息

100 项与 Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital) 相关的专利（医药）

登录后查看更多信息

100 项与 Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules(Beijing Tiantan Hospital) 相关的药物交易

登录后查看更多信息